Colorectal Cancer Clinical Trial
Official title:
Colorectal Cancer Control in Appalachian Churches
The purpose of this project is to conduct a community-based intervention and evaluate the independent and combined effects of two intervention strategies on primary and secondary prevention of colorectal cancer (CRC) among members of rural Appalachian churches. The sampling frame consists of all of the churches in a 7 county area of western West Virginia. Eligible churches will have at least 180 active members, will not share a common pastor, and will have no CRC control activities. Using a 2x2 experimental design, churches will be divided into two separate clusters, those with and without an existing parish nurse program. Then churches from each cluster will be randomized to one of two conditions, a natural helper or a control condition.
The purpose of this project is to conduct a community-based intervention and evaluate the
independent and combined effects of two intervention strategies on primary and secondary
prevention of colorectal cancer (CRC) among members of rural Appalachian churches. Many
regions of Appalachia have high poverty, low education, and high unemployment. Health
disparities are great in this region and social and behavioral factors put many individuals
at high risk for increased mortality from CRC.
The sampling frame consists of all churches in a 7 county area of western West Virginia.
Eligible churches will have at least 180 active members, will not share a common pastor, and
have no CRC control activities. Using a 2x2 experimental design, churches will be divided
into two separate clusters, those with and without an existing parish nurse program. Then
churches from each cluster will be randomized to one of two conditions, a natural helper or
control condition.
Eligible church members will be adult males and females who are identified through member
lists provided by the recruited churches. Because the primary outcome variable is CRC
screening, at least half of the recruited church members must be age 50 and older, report no
history of CRC, and have not recently completed CRC screening. Interested members will be
asked to complete an informed consent form detailing participation in either the
intervention or control arm of the study. The control group will be offered other health
promotion interventions through the church and the CRC educational materials after data
collection is completed.
Data will be collected before and after the intervention activities. Study participants will
complete a paper and pencil survey at the church at each measurement point (baseline,
follow-up). The baseline survey will assess sociodemographics, psychosocial information,
stage of change, self-efficacy, health beliefs, barriers to change, health behavior
knowledge and practices involving diet, physical activity, and CRC screening. The follow-up
survey will assess body mass index, dietary intake, physical activity level, and CRC
screening by FOBT, flexible sigmoidoscopy, and colonoscopy.
The primary hypothesis to be tested is that the combination of these two community-based
intervention strategies will be most effective overall. To evaluate the effectiveness of the
intervention strategies, the proportions in outcome measures between each intervention, the
combined intervention, and control groups will be compared.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |